Phase Genomics

Phase Genomics is a biotechnology startup based in the United States, founded in 2015 with the mission of empowering scientists with state-of-the-art genomic tools. The company specializes in Hi-C genomics, metagenomics, and epigenomics, applying proximity-ligation methods to enable chromosome-scale genome assembly, metagenomic deconvolution, and analysis of structural genomic variation and genome architecture. They offer a comprehensive portfolio of laboratory and computational services and products, including Hi-C kits for plants, animals, microbes, and human samples, as well as industry-leading genome and metagenome assembly and analysis software. In March 2024, Phase Genomics secured a significant $1.50M grant investment from the Bill & Melinda Gates Foundation, marking a milestone in their funding journey. The company has attracted attention and support from notable investors, reflecting confidence in their innovative approach to genomic research and analysis. Phase Genomics serves a diverse range of academic and commercial researchers, providing essential tools and services that contribute to accelerating breakthrough discoveries in various fields and industries. As a pioneer in genomic technology, Phase Genomics continues to make significant strides in advancing the understanding of biology and driving impactful discoveries.